| Name | Title | Contact Details |
|---|
At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.
Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe.
Enochian BioSciences (formerly DanDrit Biotech USA Inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for HIV/AIDS and cancer.
Prevention Point Philadelphia is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saint Peters Healthcare System, Inc. is a New Jersey nonprofit corporation sponsored by the Roman Catholic Diocese of Metuchen. The System consists of Saint Peters University Hospital, Saint Peters Health & Management Services Corporation and The Saint Peters Foundation. Saint Peters Healthcare System was formed in 2007 and reflects the expansive scope of health and wellness services we offer to our community. Our services are offered to all. We are a Catholic institution with a capital C and a small c. We draw inspiration from our religious heritage. Our care for others is universal, extending to those of other faiths and in some cases, of no faith whatsoever. Without question, the fact that ours is a faith-based healthcare delivery system is of primary significance. At Saint Peters Healthcare System, you will find leading-edge technology and an experienced staff. You will also find the trust and compassion that we have always been known for.